Fred Hutchinson Cancer Research Center

Latest articles

9m
Daily Mail
A quarter of cancer patients use medical marijuana, study findsA QUARTER of cancer patients use marijuana to treat their symptoms and 75% want
Daily Mail / Posted 9 minutes ago
A QUARTER of cancer patients use marijuana to treat their symptoms and 75% want to try it, study finds A report from Fred Hutchinson Cancer Research Center has found that about 25% of cancer patients have used marijuana as a treatment in the past... Read more
2 related articles
2h
New Kerala
Up to one-quarter of cancer patients use marijuana: newkerala news #274701treatment, but patterns of use among cancer patients are not well known. To inv
New Kerala / Posted 2 hours ago
treatment, but patterns of use among cancer patients are not well known. To investigate, Steven Pergam, MD, MPH, of the Fred Hutchinson Cancer Research Center and his colleagues surveyed 926 patients at the Seattle Cancer Center Alliance. The... Read more
2 related articles
9h
International Business Times
A quarter of cancer patients use cannabis to feel better, where it's legal of them are seeking information from alternate non-scientific sources," said st
International Business Times / Posted 9 hours ago
of them are seeking information from alternate non-scientific sources," said study author Steven Pergam, a doctor at the Fred Hutchinson Cancer Research Center. "We hope that this study helps to open up the door for more studies aimed at... Read more
2 related articles
1d
The Bismarck Tribune
Bismarck man sees success from new cancer treatmentphone and computer with doctors trying to get him into a trial. With her hard
The Bismarck Tribune / Posted yesterday
phone and computer with doctors trying to get him into a trial. With her hard work, he would be accepted into a trial at Fred Hutchinson Cancer Research Center in Seattle. They had conducted about 100 at the time. “They weren’t all successful,... Read more
2d
WPXI Pittsburgh
Breakthrough gene therapy for childhood leukemia clearedcancers - a harder next step. "Although narrow in scope, today's FDA ruling is
WPXI Pittsburgh / Posted 2 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
3d
Business Wire
Juno Therapeutics Prices $250 Million Follow-on OfferingJuno brings together innovative technologies from some of the world's leading r
Business Wire / Posted 3 days ago
Juno brings together innovative technologies from some of the world's leading research institutions, including the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, Seattle Children's Research Institute (SCRI),... Read more
3d
Business Wire
Juno Therapeutics Opens New Headquarters and Research CenterJuno brings together innovative technologies from some of the world's leading r
Business Wire / Posted 3 days ago
Juno brings together innovative technologies from some of the world's leading research institutions, including the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, Seattle Children's Research Institute (SCRI),... Read more
4d
Crosscut
5 things to do in Seattle this weekendBeer Festival will take place at the Seattle Center, with over 80 pumpkin beers
Crosscut / Posted 4 days ago
Beer Festival will take place at the Seattle Center, with over 80 pumpkin beers on tap and 100% of proceeds going to Fred Hutchinson Cancer Research Center. Elysian Brewery in Georgetown, Saturday 9/23 from 12-4, Free Maybe it’s the... Read more
9d
The Seattle Times
Juno Therapeutics ready for another round in war on cancerwhich can lead to dangerously high fevers and precipitous drops in blood pressu
The Seattle Times / Posted 9 days ago
which can lead to dangerously high fevers and precipitous drops in blood pressure. Stanley Riddell, an oncologist with the Fred Hutchinson Cancer Research Center in Seattle and a leading expert in the field of immunotherapy, said researchers are... Read more
19d
Eye Witness News
Prostate cancer test saves lives, risks remaintogether indicate there is an important benefit,” said Ruth Etzioni, who is the
Eye Witness News / Posted 19 days ago
together indicate there is an important benefit,” said Ruth Etzioni, who is the senior author of the analysis from the Fred Hutchinson Cancer Research Center in Seattle, Washington. A flaw of the earlier trials is that some men who were... Read more
8 related articles
19d
SaukValley.com
PSA screening for prostate cancer saves lives after all, study saysMedicine, now calls those recommendations into question. The authors of the stu
SaukValley.com / Posted 19 days ago
Medicine, now calls those recommendations into question. The authors of the study, led by biostatistician Ruth Etzioni of Fred Hutchinson Cancer Research Center in Seattle, concluded that screening men over age 55 “can significantly reduce the... Read more
8 related articles
19d
The Hill
Drug companies need to pay patients for clinical trialssurprising is that 20 percent of oncology trials fail because they don’t enroll
The Hill / Posted 19 days ago
surprising is that 20 percent of oncology trials fail because they don’t enroll enough patients according to a study by the Fred Hutchinson Cancer Research Center and the University of Washington. Pharmaceutical companies are desperate to get... Read more
19d
Newsmax
8 Ways to Reduce Inflammation – Underlying Cause of Many Diseasesbe in a constant state of inflammation, says Catherine Duggan, staff scientist
Newsmax / Posted 19 days ago
be in a constant state of inflammation, says Catherine Duggan, staff scientist in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center in Seattle. Avoid cooking foods at high temperatures. According to the experts at the... Read more
19d
CBS News
Studies may boost PSA screening for prostate cancercorrelated with the reduced risk of prostate cancer death," said senior researc
CBS News / Posted 19 days ago
correlated with the reduced risk of prostate cancer death," said senior researcher Ruth Etzioni, a biostatistician with the Fred Hutchinson Cancer Research Center in Seattle. "There are definitely harms and, on average, in a population probably... Read more
8 related articles
20d
Baltimore Sun
PSA screening for prostate cancer saves lives after all, study saysMedicine, now calls those recommendations into question. The authors of the stu
Baltimore Sun / Posted 20 days ago
Medicine, now calls those recommendations into question. The authors of the study, led by biostatistician Ruth Etzioni of Fred Hutchinson Cancer Research Center in Seattle, concluded that screening men over age 55 “can significantly reduce the risk... Read more
8 related articles
20d
Medical News Today
Prostate cancer: PSA screening does lower death risk, says reviewof death from prostate cancer, suggests a new review. According to the review
Medical News Today / Posted 20 days ago
of death from prostate cancer, suggests a new review. According to the review authors - led by Ruth Etzioni, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, WA - their findings suggest that guidelines for PSA screening may need to... Read more
8 related articles
20d
Newsmax
Prostate Cancer Test Saves Lives, Risks Remaintogether indicate there is an important benefit," said Ruth Etzioni, who is the
Newsmax / Posted 20 days ago
together indicate there is an important benefit," said Ruth Etzioni, who is the senior author of the analysis from the Fred Hutchinson Cancer Research Center in Seattle, Washington. A flaw of the earlier trials is that some men who were... Read more
8 related articles
20d
Channel NewsAsia
Prostate cancer test saves lives, risks remaintogether indicate there is an important benefit," said Ruth Etzioni, who is the
Channel NewsAsia / Posted 20 days ago
together indicate there is an important benefit," said Ruth Etzioni, who is the senior author of the analysis from the Fred Hutchinson Cancer Research Center in Seattle, Washington. A flaw of the earlier trials is that some men who were... Read more
8 related articles
24d
5KSDK St. Louis
FDA approves breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
5KSDK St. Louis / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
WCNC Charlotte
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
WCNC Charlotte / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
KFVS 12 Cape Girardeau
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
KFVS 12 Cape Girardeau / Posted 24 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
The Mercury News
Leukemia-fighting gene therapy has ups (it usually works) and downs ($475K price, brutal side effects)cancers – a harder next step. “Although narrow in scope, today’s FDA ruling is
The Mercury News / Posted 24 days ago
cancers – a harder next step. “Although narrow in scope, today’s FDA ruling is a milestone,” said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
Crain's Chicago Business
Breakthrough gene therapy for childhood leukemia gets FDA OKcancers — a harder next step. "Although narrow in scope, today's FDA ruling is
Crain's Chicago Business / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
Newsmax
Leukemia 'Living Drug' Approved for Childhood Diseasecancers — a harder next step. "Although narrow in scope, today's FDA ruling is
Newsmax / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
WLTX-TV Columbia
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
WLTX-TV Columbia / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
WZZM 13 Grand Rapids
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
WZZM 13 Grand Rapids / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
KTHV Little Rock
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
KTHV Little Rock / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
WFAA Dallas-Fort Worth
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
WFAA Dallas-Fort Worth / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
WGRZ-TV Buffalo
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
WGRZ-TV Buffalo / Posted 24 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
Business Insider
A medical breakthrough that hacks genes to fight cancer just got approved, and it's the beginning of 'a big new field of medicine'In this photo taken March 29, 2017, Dr. David Maloney of the Fred Hutchinson Ca
Business Insider / Posted 24 days ago
In this photo taken March 29, 2017, Dr. David Maloney of the Fred Hutchinson Cancer Research Center is greeted by patient Ken Shefveland, whose lymphoma was successfully treated with CAR-T cell therapy.AP/Elaine Thompson The FDA approved the... Read more
300 related articles
24d
WSB-TV 2 Atlanta
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
WSB-TV 2 Atlanta / Posted 24 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
Los Angeles Daily News
Leukemia-fighting gene therapy has ups (it usually works) and downs (you won’t believe what it costs, side effects are brutal)cancers — a harder next step. “Although narrow in scope, today’s FDA ruling is
Los Angeles Daily News / Posted 24 days ago
cancers — a harder next step. “Although narrow in scope, today’s FDA ruling is a milestone,” said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
24d
ABC 7 Gulfshore News
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
ABC 7 Gulfshore News / Posted 24 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
FOX 8 Cleveland
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. “Although narrow in scope, today’s FDA ruling is
FOX 8 Cleveland / Posted 25 days ago
cancers — a harder next step. “Although narrow in scope, today’s FDA ruling is a milestone,” said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
San Antonio Express-News
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
San Antonio Express-News / Posted 25 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
WHAS TV11 Louisville
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
WHAS TV11 Louisville / Posted 25 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
The Sacramento Bee
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. "Although narrow in scope, today's FDA ruling is
The Sacramento Bee / Posted 25 days ago
cancers — a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
Q13 FOX Seattle
U.S. clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. “Although narrow in scope, today’s FDA ruling is
Q13 FOX Seattle / Posted 25 days ago
cancers — a harder next step. “Although narrow in scope, today’s FDA ruling is a milestone,” said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
KING5 Seattle
FDA approves the first immunotherapy drug for childhood leukemiause to treat cancer. That is unprecedented, it’s never happened before,” said D
KING5 Seattle / Posted 25 days ago
use to treat cancer. That is unprecedented, it’s never happened before,” said Dr. Damian Green, a clinical researcher at Fred Hutchinson Cancer Research Center. Both Fred Hutchinson Cancer Research Center and the Ben Towne Center for Childhood... Read more
300 related articles
25d
WGEM Quincy
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
WGEM Quincy / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
KFJX Pittsburg
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
KFJX Pittsburg / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
WSFA 12 Montgomery
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
WSFA 12 Montgomery / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
14 WFIE Evansville
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
14 WFIE Evansville / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
KXXV Waco
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
KXXV Waco / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
WAVE 3 Louisville
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
WAVE 3 Louisville / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
The Seattle Times
US clears breakthrough gene therapy for childhood leukemiacancers — a harder next step. “Although narrow in scope, today’s FDA ruling is
The Seattle Times / Posted 25 days ago
cancers — a harder next step. “Although narrow in scope, today’s FDA ruling is a milestone,” said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
WDAM-TV Hattiesburg
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
WDAM-TV Hattiesburg / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
WECT 6 Wilmington
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
WECT 6 Wilmington / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
ABC 7 Gulfshore News
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
ABC 7 Gulfshore News / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
25d
9&10 News Cadillac
US clears breakthrough gene therapy for childhood leukemiacancers - a harder next step. "Although narrow in scope, today's FDA ruling is
9&10 News Cadillac / Posted 25 days ago
cancers - a harder next step. "Although narrow in scope, today's FDA ruling is a milestone," said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of... Read more
300 related articles
More

In this news